Full-Time

Chief Accounting Officer

Diabetes

Updated on 6/12/2025

Deadline 6/23/25
Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Compensation Overview

$281.9k - $469.8k/yr

+ Short-term Incentive + Long-term Incentive

Expert

Northridge, Los Angeles, CA, USA

This position is based in Northridge, CA, part of the Los Angeles metropolitan area.

Category
Cost Accounting
Financial Accounting
Financial Controller
Management Accounting
Accounting
Requirements
  • Bachelor’s degree in Accounting, Finance, or a related field.
  • CPA or equivalent certification.
  • 15+ years of progressive accounting and financial leadership experience (or 13+ with an advanced degree), including 13+ years of managerial experience.
Responsibilities
  • Lead all accounting and reporting aspects of the IPO and corporate separation process.
  • Own technical accounting decisions, IPO disclosures, and coordination with auditors, legal, and external advisors.
  • Ensure financial statements, internal controls, and infrastructure meet public company standards from Day 1.
  • Partner with the CFO on S-1 preparation, investor communications, earnings releases, and quarterly reporting.
  • Oversee global accounting operations, including monthly/quarterly close, consolidation, and external reporting.
  • Lead preparation and filing of all SEC documents (10-K, 10-Q, 8-K, etc.), ensuring timeliness and compliance.
  • Establish robust accounting policies aligned with U.S. GAAP and evolving regulatory requirements.
  • Manage financial systems strategy (ERP, chart of accounts) to drive scalability and automation.
  • Build and maintain a SOX-compliant control environment across the enterprise.
  • Lead relationships with internal and external auditors; manage all audit processes and timelines.
  • Design and enforce policies across accounting, treasury, procurement, and tax.
  • Oversee enterprise risk management in collaboration with legal and compliance teams.
  • Manage accounting operations across international subsidiaries, plants, and distribution hubs.
  • Lead global consolidations, foreign currency accounting, and intercompany transactions.
  • Implement effective transfer pricing policies and support tax strategy and compliance.
  • Act as a strategic finance partner to R&D, supply chain, and commercial leaders.
  • Build and lead a high-performing global accounting organization, including corporate and regional controllership.
  • Recruit, develop, and retain top accounting talent across disciplines and geographies.
  • Foster a culture of continuous improvement, accountability, and operational excellence.
Desired Qualifications
  • Demonstrated success in IPO, SPAC, or spin-off execution.
  • Deep knowledge of U.S. GAAP, SEC reporting, and SOX 404 compliance.
  • Experience in MedTech, life sciences, or complex manufacturing environments.
  • Strong command of global accounting topics including foreign currency, transfer pricing, and international consolidation.
  • Expertise in ERP systems (e.g., SAP, Oracle) and financial reporting tools.
  • Proven ability to build scalable financial infrastructure in high-growth settings.
  • Excellent communication skills, with experience engaging boards and audit committees.
  • A strategic mindset with the ability to lead through change and ambiguity.

Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals and healthcare professionals around the world. Medtronic stands out from competitors by not only focusing on product development but also offering comprehensive services such as training for healthcare providers and patient management programs. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through its advanced medical solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for remote patient monitoring aligns with Medtronic's partnership with Corsano Health.
  • Growing interest in wearable devices supports Medtronic's distribution agreement for Corsano's wearable.
  • The trend towards personalized medicine benefits Medtronic's neurostimulation and diabetes management technologies.

What critics are saying

  • Voluntary recall of ventilators due to patient death may harm Medtronic's reputation.
  • Spin-off of Diabetes business into MiniMed may cause operational disruptions.
  • Partnership with Corsano Health may face integration and execution challenges.

What makes Medtronic unique

  • Medtronic is a global leader in medical technology with operations in over 150 countries.
  • The company offers a comprehensive suite of products and services for various medical conditions.
  • Medtronic invests heavily in R&D to innovate and bring new products to market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Medical Device Network
Jun 13th, 2025
FDA tags Medtronic's voluntary ventilator recall as Class I after patient death

Medtronic has announced a voluntary recall of select Newport HT70 and Newport HT70 Plus ventilators and certain related service parts for the devices.

Hit Consultant
Jun 13th, 2025
Medtronic Rebrands Diabetes Business As “Minimed” Ahead Of Spin-Off

Medtronic Rebrands Diabetes Business as “MiniMed” Ahead of Spin-Off. by Jasmine Pennic 06/13/2025 Leave a Comment. What You Should Know: – Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide.The announcement marks a significant step in the intended separation of Medtronic’s Diabetes business into a new, independent entity.Simplify Life with DiabetesThe new MiniMed’s mission is to make diabetes more predictable so that everyone can embrace life to the fullest. The company aims to address the constant mental and physical demands required to keep glucose levels in a healthy range, developing technology that helps push the daily burden of diabetes management into the background.Based in Northridge, California, the Diabetes business consists of a passionate team of more than 8,000 employees. Medtronic is targeting the completion of the planned separation within 18 months of its initial announcement, subject to customary conditions and legal requirements.“Our journey began in 1983, when visionary entrepreneur Alfred E

The Healthcare Technology Report
Jun 9th, 2025
Medtronic to Spin Off Its Diabetes Business into an Independent Company

Medtronic expects to execute the separation through an initial public offering followed by a split-off transaction.

Horoekareading
Jun 2nd, 2025
The Top 5 Medical Device Animation Video Companies

Ghost Productions has worked with some of the biggest names in the medical device industry, including Medtronic, Boston Scientific, and Johnson & Johnson.

Siam News
May 23rd, 2025
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

GALWAY, Ireland, May 24, 2025 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.